Anderson Hoagland & Co’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-32,694
| Closed | -$2.39M | – | 131 |
|
|
2023
Q3 | $2.39M | Buy |
32,694
+95
| +0.3% | +$6.94K | 0.32% | 78 |
|
|
2023
Q2 | $2.71M | Sell |
32,599
-180
| -0.5% | -$15K | 0.35% | 75 |
|
|
2023
Q1 | $2.5M | Sell |
32,779
-160
| -0.5% | -$12.2K | 0.36% | 73 |
|
|
2022
Q4 | $2.8M | Sell |
32,939
-213
| -0.6% | -$18.1K | 0.41% | 70 |
|
|
2022
Q3 | $2.63M | Buy |
33,152
+16,797
| +103% | +$1.33M | 0.42% | 65 |
|
|
2022
Q2 | $1.37M | Sell |
16,355
-9,938
| -38% | -$829K | 0.21% | 87 |
|
|
2022
Q1 | $2.36M | Buy |
26,293
+21
| +0.1% | +$1.89K | 0.3% | 71 |
|
|
2021
Q4 | $2.42M | Buy |
26,272
+289
| +1% | +$26.6K | 0.32% | 76 |
|
|
2021
Q3 | $3.27M | Buy |
25,983
+1,035
| +4% | +$130K | 0.42% | 62 |
|
|
2021
Q2 | $3.38M | Buy |
24,948
+432
| +2% | +$58.5K | 0.43% | 60 |
|
|
2021
Q1 | $3.33M | Sell |
24,516
-1,949
| -7% | -$264K | 0.47% | 57 |
|
|
2020
Q4 | $3.73M | Buy |
+26,465
| New | +$3.73M | 0.59% | 50 |
|